Chemoinformaics analysis of (7Z,10Z)-HEXADECADIENAL
| Molecular Weight | 236.399 | nRot | 12 |
| Heavy Atom Molecular Weight | 208.175 | nRig | 3 |
| Exact Molecular Weight | 236.214 | nRing | 0 |
| Solubility: LogS | -4.811 | nHRing | 0 |
| Solubility: LogP | 5.566 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 46.1922 |
| nHD | 0 | BPOL | 28.9578 |
| QED | 0.258 |
| Synth | 2.584 |
| Natural Product Likeliness | 1.679 |
| NR-PPAR-gamma | 0.097 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.233 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.698 |
| MDCK | 0.0000166 |
| BBB | 0.99 |
| PPB | 0.908712 |
| VDSS | 2.722 |
| FU | 0.041697 |
| CYP1A2-inh | 0.768 |
| CYP1A2-sub | 0.421 |
| CYP2c19-inh | 0.523 |
| CYP2c19-sub | 0.487 |
| CYP2c9-inh | 0.276 |
| CYP2c9-sub | 0.93 |
| CYP2d6-inh | 0.271 |
| CYP2d6-sub | 0.733 |
| CYP3a4-inh | 0.541 |
| CYP3a4-sub | 0.136 |
| CL | 2.715 |
| T12 | 0.308 |
| hERG | 0.169 |
| Ames | 0.723 |
| ROA | 0.508 |
| SkinSen | 0.99 |
| Carcinogencity | 0.607 |
| EI | 0.975 |
| Respiratory | 0.964 |
| NR-Aromatase | 0.67 |
| Antiviral | Yes |
| Prediction | 0.772702 |